Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon — LISH  

Hepatic Flexure Colon Cancer Clinical Trial

Official title: An Open, Single-arm, Single Center, Clinical Trial to Investigate the Feasibility and Safety of Laparoscopic Ileocecus-sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon

Status Completed

Clinical Trial Summary

To investigate whether laparoscopic ileocecus-sparing right hemicolectomy is feasible and oncologically safe

Clinical Trial Description

Our study is a single arm, single center clinical trial. The enrolled patients will accept laparoscopic ileocecus-sparing right hemicolectomy. The primary endpoint: postoperative complications, 1-year local recurrence. The second endpoint: conversion to conventional right hemicolectomy, time to first flatus after surgery, number of harvested lymph nodes, 3-year disease free survival, R0 resection, Specimen morphometry ;

Related Conditions & MeSH terms

• Colonic Neoplasms
• Hepatic Flexure Colon Cancer
• Proximal Transverse Colon Cancer

• NCT number: NCT04479111
• Study type: Interventional
• Source: Zhejiang University
• Status: Completed
• Phase: N/A
• Start date: January 1, 2020
• Completion date: January 1, 2023